Clinical Trial Update: Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating temozolomide plus thalidomide for brain metastases arising from melanoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• Temodar (Temozolomide)
• Thalomid (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 2 | Status: COMPLETED